Abstract:Influenza A virus (IAV) expresses several accessory proteins to limit host anti-viral restriction factors to facilitate viral replication. The Ten-Eleven Translocation 2 (TET2) is a methylcytosine dioxygenase that promotes DNA demethylation by catalyzing the oxidation of 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC), which plays a vital role in hematopoiesis and immunity. Here we report that TET2 is a host restriction factor that limits IAV replication. But IAV endoribonuclease PA-X is able to remove the replication restriction by binding to TET2 mRNA and driving TET2 mRNA degradation to reduce TET2 expression during infection. Genetic inactivation of TET2 markedly enhances IAV replication in vitro and in vivo . Mechanistically, we found that TET2 regulates demethylation and transcription of STAT1 and some interferon-stimulated genes (ISGs), including ISG15 , ISG20 , and IFIT5 , so the loss of TET2 greatly impairs type I Interferon signaling. Furthermore, we confirmed that TET2-mediated demethylation of the STAT1 gene is critical for interferon anti-viral activity. Our study demonstrates that the host TET2 is essential to the innate immune response against IAV infection. Influenza A virus (IAV) severely risks public health and economic stability. The endoribonuclease PA-X of IAV can limit host gene expression to facilitate viral replication. The Ten-Eleven Translocation 2 (TET2)-mediated DNA demethylation, which promotes gene transcription, is essential for host hematopoiesis and immunity. Here, we report that host TET2 mRNA can be targeted by PA-X protein for degradation, resulting in reduced TET2 expression during IAV infection. Notably, loss of TET2 markedly enhances IAV replication. Our study further confirmed that TET2 is responsible for the demethylation and expression of STAT1 , ISG15 , ISG20 , and IFIT5 genes, which belong to type I interferon signaling and contribute to anti-viral immune response. Additionally, we identified that STAT1 is a critical factor in response to TET2 in the anti-IAV signaling. Taken together, we demonstrated that IAV inhibits TET2 expression by PA-X to reduce STAT1 and ISG expression, leading to immune escape and enhanced viral replication. Our research can provide a novel target for therapeutics to inhibit IAV infection and reduce pathology.

TET3 Inhibits Type I IFN Production Independent of DNA Demethylation.

Single-nucleotide methylation specifically represses type I interferon in antiviral innate immunity

Methyltransferase SETD2-Mediated Methylation of STAT1 is Critical for Interferon Antiviral Activity.

Noncanonical NF-κB Pathway Controls the Production of Type I Interferons in Antiviral Innate Immunity

Gcn5 and PCAF Negatively Regulate Interferon‐β Production Through HAT‐independent Inhibition of TBK1

NBR1 Mediates Autophagic Degradation of IRF3 to Negatively Regulate Type I Interferon Production.

IFITM3 Inhibits Virus-Triggered Induction of Type I Interferon by Mediating Autophagosome-Dependent Degradation of IRF3.

MIP-T3 is a negative regulator of innate type I IFN response

STAT3 Inhibits Autocrine IFN Signaling in Type I Conventional Dendritic Cells

Innate antiviral host defense attenuates TGF-β function through IRF3-mediated suppression of Smad signaling.

Negative Regulation of Interferon-Induced Transmembrane Protein 3 by Set7-Mediated Lysine Monomethylation

Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation.

Tumor Necrosis Factor--Induced Protein 8-Like 2 Negatively Regulates Innate Immunity Against RNA Virus by Targeting RIG-I in Macrophages

Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity

TRIM9 short isoform preferentially promotes DNA and RNA virus-induced production of type I interferon by recruiting GSK3β to TBK1

Asymmetric arginine dimethylation of cytosolic RNA and DNA sensors by PRMT3 attenuates antiviral innate immunity

Ttll12 Inhibits the Activation of Cellular Antiviral Signaling Through Interaction with Visa/Mavs

OTUD1 Negatively Regulates Type I IFN Induction by Disrupting Noncanonical Ubiquitination of IRF3

Selective autophagy controls the stability of transcription factor IRF3 to balance type I interferon production and immune suppression

RNA-binding protein YTHDF3 suppresses interferon-dependent antiviral responses by promoting FOXO3 translation

Influenza A virus inhibits TET2 expression by endoribonuclease PA-X to attenuate type I interferon signaling and promote viral replication